Pepkon Selected for PSCC Support Program!

PepKon is honored to be chosen as one of the seven projects selected by the PSCC to benefit from their innovation support program. This opportunity will provide access to leading experts, specialized training, potential investors, and key industry partners, further accelerating our work in peptide therapeutics for oncology.

The PSCC continues its selection process, with upcoming deadlines for project evaluations in June and August. As their offerings expand, selected projects gain access to preclinical and clinical platforms, data resources, specialized spaces, and funding opportunities.

We extend our gratitude to the PSCC team for this incredible opportunity, and we look forward to leveraging this support to drive the next phase of our research and development in peptide drug discovery and targeted cancer therapies.

Stay tuned for updates as PepKon advances its innovative solutions in oncology-focused peptide engineering!